Free CME from PeerView


Surgery CME

Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Linking Immunotherapy to Better Outcomes in Resectable Melanoma: Guidance on Integrating Immune-Based Adjuvant and Neoadjuvant Options
Jennifer Wargo, MD, MMSc
March 10, 2022
Credits: 0.5 CME
Penn State College of Medicine
Hope Is on the Horizon: The Clinical Potential of Emerging Disease-Modifying Therapies for Managing Complement 3 Glomerulopathy
Carla M. Nester, MD, MSA, FASN
February 24, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?
Nasser Altorki, MD / Jonathan D. Spicer, MD / PhD, FRCSC
February 22, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
University of Florida College of Medicine
Short Bowel Syndrome IMPACT Initiative: An Initiative to Individualize Treatment and Improve the Pediatric to Adult Healthcare Transition
Sam Cheng, MD/Angela Pham, MD
February 16, 2022
William D. Tap, MD
Credits: 0.25 CME / MOC
Medical Learning Institute, Inc.
Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options
William D. Tap, MD
January 13, 2022
Credits: 0.5 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy
Sara M. Tolaney, MD, MPH
December 28, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC
David R. Jones, MD
November 19, 2021
Credits: 1 CME
Medical Learning Institute, Inc.
Immunotherapy at the Cutting Edge in Resectable Esophageal/GEJ Cancer: Preparing Thoracic Surgeons and the Broader Multidisciplinary Team to Navigate Changing Standards of Care
Ronan J. Kelly, MD, MBA
November 04, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team
October 29, 2021
Credits: 0.25 CME
Johns Hopkins University School of Medicine
Advances in the Management of IBD: Expert Insight on What’s New and What’s Next
Aline Charabaty, MD, AGAF, FACG
September 29, 2021
Credits: 1 CME / MOC / CC / NCPD
PVI, PeerView Institute for Medical Education
Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical
September 02, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
Credits: 1.00 CME
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 07, 2021
Credits: 1.00 CME / CC
Medical Learning Institute, Inc.
Immune Checkpoint Inhibitor Therapy for Locally Advanced and Early-Stage Esophageal/GEJ Cancer: The Latest Evidence and Implications for Thoracic Surgeons and the Multidisciplinary Care Team
Ronan J. Kelly, MD, MBA
May 25, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced and Earlier Stages of Lung Cancer
Brendon M. Stiles, MD
May 21, 2021
Medical Learning Institute, Inc.
The Path Forward for Immunotherapy in Resectable Melanoma: Principles and Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy
Jennifer Wargo, MD, MMSc
April 12, 2021
The Medical College of Wisconsin
How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
Ruben A. Mesa, MD, FACP
February 26, 2021
Penn State College of Medicine
Optimizing Maintenance Immunosuppressive Therapy in Kidney Transplantation: Examining Current and Future Strategies to Preserve Graft Function and Maximize Long-Term Outcomes
Titte R. Srinivas, MD, FAST
February 25, 2021
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
February 23, 2021
The Medical College of Wisconsin
The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
Robert Z. Orlowski, MD, PhD
February 17, 2021
The Medical College of Wisconsin
Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
February 16, 2021
Medical Learning Institute, Inc.
Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
Steven Brem, MD
December 29, 2020
Medical Learning Institute, Inc.
Taking the Leap With Immunotherapy in Resectable Melanoma: Immune Checkpoint Inhibitors as Adjuvant and Neoadjuvant Therapy and Other Intersections With Surgical Management
Jennifer Wargo, MD, MMSc
September 23, 2020
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView